Synergistic action of prolactin on PRL-Inducible protein gene human breast cancer cells: A (PRL) and androgen expression in unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor

被引:35
作者
Carsol, JL [1 ]
Gingras, S [1 ]
Simard, J [1 ]
机构
[1] Univ Laval, Med Ctr, Canada Res Chair Oncogenet, Oncol & Mol Endocrinol Res Ctr, Quebec City, PQ G1V 4G2, Canada
关键词
D O I
10.1210/me.16.7.1696
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The signal transducer and activator of transcription 5 (Stat5) has been shown to cooperate with some nuclear receptors. However, an interaction has never been demonstrated with the androgen receptor (AR). Given that the PRL-inducible protein/gross cystic disease fluid-15 (PIP/GCDFP-15) is both a PRL-controlled and an androgen-controlled protein, we used its promoter region to investigate the potential interaction between Stat5 and androgen receptor. Dihydrotestosterone or PRL alone slightly modulated or did not modulate the luciferase activity of all reporter gene constructs. In contrast, a maximal increase was observed using the -1477+42 reporter gene construct after exposure to both dihydrotestosterone and PRL. The requirement of half-site androgen-responsive elements and two consensus Stat5-binding elements, Stat5#1 and Stat5#2, was determined by site-directed mutagenesis. Activated Stat5B binds with a higher affinity to Stat5#2 than to Stat5#1. Stat5ADelta749 and Stat5BDelta754 mutants demonstrated that the Stat5 trans-activation domain is involved in the hormonal cooperation. The cooperation depends on the PRL-induced phosphorylation on Tyr(694) in Stat5A and Tyr(699) in Stat5B, as demonstrated using the Stat5AY694F and Stat5BY699F proteins. The use of AR Q798E, C619Y, and C784Y mutants showed that transactivation, DNA-binding, and ligand-binding domains of AR are essential. Our study thus suggests a functional cooperation between AR and Stat5.
引用
收藏
页码:1696 / 1710
页数:15
相关论文
共 98 条
  • [1] ALLEGRA JC, 1979, CANCER RES, V39, P1447
  • [2] Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha
    Bhattacharya, S
    Eckner, R
    Grossman, S
    Oldread, E
    Arany, Z
    DAndrea, A
    Livingston, DM
    [J]. NATURE, 1996, 383 (6598) : 344 - 347
  • [3] BISWAS R, 1987, CANCER RES, V47, P3509
  • [4] Cross-talk between Stat5b and estrogen receptor-α and -β in mammary epithelial cells
    Björnström, L
    Kilic, E
    Norman, M
    Parker, MG
    Sjöberg, M
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2001, 27 (01) : 93 - 106
  • [5] Interleukin-4 and interleukin-13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells
    Blais, Y
    Gingras, S
    Haagensen, DE
    Labrie, F
    Simard, J
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1996, 121 (01) : 11 - 18
  • [6] POTENT STIMULATORY EFFECT OF INTERLEUKIN-1-ALPHA ON APOLIPOPROTEIN-D AND GROSS CYSTIC-DISEASE FLUID PROTEIN-15 EXPRESSION IN HUMAN BREAST-CANCER CELLS
    BLAIS, Y
    SUGIMOTO, K
    CARRIERE, MC
    HAAGENSEN, DE
    LABRIE, F
    SIMARD, J
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1994, 59 (03) : 400 - 407
  • [7] A single amino acid in the DNA binding regions of STAT5A and STAT5B confers distinct DNA binding specificities
    Boucheron, C
    Dumon, S
    Constantino, S
    Santos, R
    Moriggl, R
    Hennighausen, L
    Gisselbrecht, S
    Gouilleux, F
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (51) : 33936 - 33941
  • [8] STATs in oncogenesis
    Bowman, T
    Garcia, R
    Turkson, J
    Jove, R
    [J]. ONCOGENE, 2000, 19 (21) : 2474 - 2488
  • [9] The role of STATs in transcriptional control and their impact on cellular function
    Bromberg, J
    Darnell, JE
    [J]. ONCOGENE, 2000, 19 (21) : 2468 - 2473
  • [10] BRYAN RM, 1984, CANCER, V54, P2436, DOI 10.1002/1097-0142(19841201)54:11<2436::AID-CNCR2820541121>3.0.CO